• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由免疫检查点相关基因IDO1驱动的肿瘤浸润性CD8 + T细胞与宫颈癌预后相关。

Tumor-Infiltrating CD8+ T Cells Driven by the Immune Checkpoint-Associated Gene IDO1 Are Associated With Cervical Cancer Prognosis.

作者信息

Zhang Shun, Wan Junhui, Chen Minjie, Cai Desheng, Xu Junlan, Chen Qi

机构信息

General Surgery Department, The First Affiliated Hospital of Nanchang University, Nanchang, China.

Obstetrics and Gynaecology Department, The First Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Front Oncol. 2021 Oct 27;11:720447. doi: 10.3389/fonc.2021.720447. eCollection 2021.

DOI:10.3389/fonc.2021.720447
PMID:34778035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8578845/
Abstract

Tumor-infiltrating immune cells, associated with tumor progression, are promising prognostic biomarkers. However, the relationship between levels of gene expression and that of immune cell infiltration in cervical cancer prognosis is unknown. In this study, three cervical cancer gene expression microarrays (GSE6791, GSE63678 and GSE55940) were obtained from the GEO database. The IDO1 gene was identified by differentially expressed gene screening. The gene expression profiles of TCGA and GTEx databases along with comprehensive bioinformatics analysis identified that the IDO1 gene was upregulated in cervical cancer with significant difference in expression at different N stages. In addition, it was also upregulated in HPV16 positive sample. The pan-cancer analysis identified that IDO1 was highly expressed in most cancers. TIMER analysis revealed that the expression of IDO1 in CESC shows positive correlation with CD8 T cells, CD4 T cells, neutrophils, dendritic cells. IDO1 expression showed remarkable positive correlation with all immune cell markers except M1 macrophages. CD8 T cell infiltration GSEA results showed that IDO1 was mainly associated with tumor immune-related signaling pathways.

摘要

与肿瘤进展相关的肿瘤浸润免疫细胞是很有前景的预后生物标志物。然而,宫颈癌预后中基因表达水平与免疫细胞浸润水平之间的关系尚不清楚。在本研究中,从GEO数据库获得了三个宫颈癌基因表达微阵列(GSE6791、GSE63678和GSE55940)。通过差异表达基因筛选鉴定出IDO1基因。TCGA和GTEx数据库的基因表达谱以及综合生物信息学分析表明,IDO1基因在宫颈癌中上调,在不同N分期的表达存在显著差异。此外,它在HPV16阳性样本中也上调。泛癌分析表明,IDO1在大多数癌症中高表达。TIMER分析显示,IDO1在CESC中的表达与CD8 T细胞、CD4 T细胞、中性粒细胞、树突状细胞呈正相关。IDO1表达与除M1巨噬细胞外的所有免疫细胞标志物均呈显著正相关。CD8 T细胞浸润GSEA结果表明,IDO1主要与肿瘤免疫相关信号通路有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/fb0aa6364687/fonc-11-720447-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/6c88d175dbda/fonc-11-720447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/db5eae440065/fonc-11-720447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/30c71136037f/fonc-11-720447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/3b5a4f1fd4e8/fonc-11-720447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/b73b87255158/fonc-11-720447-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/9e721721a793/fonc-11-720447-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/9652a8c7bf1c/fonc-11-720447-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/fb0aa6364687/fonc-11-720447-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/6c88d175dbda/fonc-11-720447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/db5eae440065/fonc-11-720447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/30c71136037f/fonc-11-720447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/3b5a4f1fd4e8/fonc-11-720447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/b73b87255158/fonc-11-720447-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/9e721721a793/fonc-11-720447-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/9652a8c7bf1c/fonc-11-720447-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9553/8578845/fb0aa6364687/fonc-11-720447-g008.jpg

相似文献

1
Tumor-Infiltrating CD8+ T Cells Driven by the Immune Checkpoint-Associated Gene IDO1 Are Associated With Cervical Cancer Prognosis.由免疫检查点相关基因IDO1驱动的肿瘤浸润性CD8 + T细胞与宫颈癌预后相关。
Front Oncol. 2021 Oct 27;11:720447. doi: 10.3389/fonc.2021.720447. eCollection 2021.
2
Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.在宫颈癌中对肿瘤源性免疫球蛋白 λ 及其相互作用蛋白的功能分析。
BMC Cancer. 2023 Oct 2;23(1):929. doi: 10.1186/s12885-023-11426-9.
3
Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.吲哚胺2,3-双加氧酶1与CD8表达谱揭示了一种预后不良的结肠癌免疫亚型。
Front Oncol. 2020 Dec 7;10:594098. doi: 10.3389/fonc.2020.594098. eCollection 2020.
4
IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration.IDO1 作为糖尿病肾病的新型免疫生物标志物及其与免疫细胞浸润的相关性。
Int Immunopharmacol. 2021 May;94:107446. doi: 10.1016/j.intimp.2021.107446. Epub 2021 Feb 10.
5
Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.CLCA2 表达降低与宫颈鳞状细胞癌患者免疫浸润相关:一项生物信息学分析。
Taiwan J Obstet Gynecol. 2021 May;60(3):480-486. doi: 10.1016/j.tjog.2021.03.016.
6
CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.CMA1 是一种强有力的预后标志物,并与胃癌的免疫浸润相关。
Autoimmunity. 2020 Jun;53(4):210-217. doi: 10.1080/08916934.2020.1735371. Epub 2020 Mar 4.
7
A comprehensive analysis of IDO1 expression with tumour-infiltrating immune cells and mutation burden in gynaecologic and breast cancers.妇科癌和乳腺癌中 IDO1 表达与肿瘤浸润免疫细胞及突变负荷的综合分析。
J Cell Mol Med. 2020 May;24(9):5238-5248. doi: 10.1111/jcmm.15176. Epub 2020 Mar 30.
8
Pan-Cancer Analysis Confirms the Prognostic and Immunological Implications of the 1,25-Dihydroxy Vitamin D3 Receptor in Cervical Squamous Cell Carcinoma.泛癌分析证实1,25 - 二羟基维生素D3受体在宫颈鳞状细胞癌中的预后及免疫影响
Cureus. 2024 Aug 12;16(8):e66743. doi: 10.7759/cureus.66743. eCollection 2024 Aug.
9
System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis.衔接蛋白相关蛋白复合物1亚基μ2(AP1M2)在恶性肿瘤中的系统分析:一项泛癌分析
J Oncol. 2022 Feb 10;2022:7945077. doi: 10.1155/2022/7945077. eCollection 2022.
10
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.LAYN 是胃癌和结肠癌的预后生物标志物,并与免疫浸润相关。
Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.

引用本文的文献

1
Role of indoleamine 2,3-Dioxygenase 1 in modulating the malignant biological behavior of cervical cancer cells through the Tryptophan-Kynurenine pathway.吲哚胺2,3-双加氧酶1通过色氨酸-犬尿氨酸途径调控宫颈癌细胞恶性生物学行为的作用
J Mol Histol. 2025 Aug 22;56(5):276. doi: 10.1007/s10735-025-10570-9.
2
The Epithelial Immune Response to Human Papillomavirus Infection.上皮细胞对人乳头瘤病毒感染的免疫反应
Pathogens. 2025 May 9;14(5):464. doi: 10.3390/pathogens14050464.
3
IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment.

本文引用的文献

1
Characteristics of Infiltrating Immune Cells and a Predictive Immune Model for Cervical Cancer.浸润性免疫细胞的特征及宫颈癌的预测性免疫模型
J Cancer. 2021 Apr 20;12(12):3501-3514. doi: 10.7150/jca.55970. eCollection 2021.
2
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data.免疫检查点抑制剂在宫颈癌中的作用:从临床前到临床数据
Cancers (Basel). 2021 Apr 26;13(9):2089. doi: 10.3390/cancers13092089.
3
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.
吲哚胺2,3-双加氧酶1(IDO1)抑制通过克服肿瘤微环境中犬尿氨酸介导的代谢抑制作用,增强了CLDN18.2嵌合抗原受体T细胞(CLDN18.2-CAR-T)细胞疗法在胃肠道癌症中的疗效。
J Transl Med. 2025 Mar 5;23(1):275. doi: 10.1186/s12967-025-06276-x.
4
High-throughput non-homogenous 3D polycaprolactone scaffold for cancer cell and cancer-associated fibroblast mini-tumors to evaluate drug treatment response.用于癌细胞和癌症相关成纤维细胞微肿瘤以评估药物治疗反应的高通量非均质3D聚己内酯支架
Toxicol Rep. 2024 Dec 12;14:101863. doi: 10.1016/j.toxrep.2024.101863. eCollection 2025 Jun.
5
CD8 T cell-based cancer immunotherapy.基于 CD8 T 细胞的癌症免疫疗法。
J Transl Med. 2024 Apr 29;22(1):394. doi: 10.1186/s12967-024-05134-6.
6
A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer.一种新型的与染色体外环状 DNA 相关的基因特征,可用于预测卵巢癌患者的总生存期。
BMC Med Genomics. 2023 Jun 19;16(1):140. doi: 10.1186/s12920-023-01576-x.
7
CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction.环状 RNA 构建的宫颈癌预后模型、免疫验证和药物预测。
Curr Oncol. 2022 Oct 25;29(11):7994-8018. doi: 10.3390/curroncol29110633.
8
IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis.IDO1 通过 ROS/p53 依赖性细胞凋亡调节上皮性卵巢癌细胞对顺铂的敏感性。
Int J Mol Sci. 2022 Oct 9;23(19):12002. doi: 10.3390/ijms231912002.
9
Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.程序性细胞坏死相关长链非编码 RNA 特征可预测宫颈鳞癌和宫颈内膜腺癌的预后和免疫反应。
Sci Rep. 2022 Sep 29;12(1):16285. doi: 10.1038/s41598-022-20858-5.
癌症中的抗原呈递:对肿瘤免疫原性和免疫逃逸的深入了解。
Nat Rev Cancer. 2021 May;21(5):298-312. doi: 10.1038/s41568-021-00339-z. Epub 2021 Mar 9.
4
Identification of prognosis-related genes in the cervical cancer immune microenvironment.识别宫颈癌免疫微环境中的预后相关基因。
Gene. 2021 Jan 15;766:145119. doi: 10.1016/j.gene.2020.145119. Epub 2020 Sep 15.
5
Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model.三联免疫疗法在黑色素瘤小鼠模型中克服肿瘤的免疫逃逸。
Front Oncol. 2020 Jun 12;10:839. doi: 10.3389/fonc.2020.00839. eCollection 2020.
6
A guide to cancer immunotherapy: from T cell basic science to clinical practice.癌症免疫疗法指南:从 T 细胞基础科学到临床实践。
Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20.
7
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.头颈部鳞状细胞癌中吲哚胺 2,3-双加氧酶 1(IDO1)的 DNA 甲基化与 IDO1 表达、HPV 状态、患者生存、免疫细胞浸润、突变负荷和干扰素 γ 特征相关。
EBioMedicine. 2019 Oct;48:341-352. doi: 10.1016/j.ebiom.2019.09.038. Epub 2019 Oct 15.
8
IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.IDO1 表达与手术切除的食管癌患者的免疫耐受和不良预后相关。
Ann Surg. 2019 Jun;269(6):1101-1108. doi: 10.1097/SLA.0000000000002754.
9
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors.吲哚胺 2,3-双加氧酶 1(IDO1)抑制剂纳武莫德(GDC-0919)联合 PD-L1 抑制剂(阿特珠单抗)治疗晚期实体瘤的 I 期研究。
Clin Cancer Res. 2019 Jun 1;25(11):3220-3228. doi: 10.1158/1078-0432.CCR-18-2740. Epub 2019 Feb 15.
10
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.高 IDO1 表达与接受根治性放化疗的肛门癌患者的不良预后相关。
Oncologist. 2019 Jun;24(6):e275-e283. doi: 10.1634/theoncologist.2018-0794. Epub 2019 Feb 12.